Genomic determinants in advanced endometrial cancer patients with sustained response to hormonal therapy- case series and review of literature

The incidence of endometrial cancer is increasing, however treatment options for advanced disease are limited. Hormonal therapy has demonstrated positive outcomes for Stage IV EC. Next generation sequencing (NGS) has increased our understanding of molecular mechanisms driving EC. In this case series...

Descripción completa

Detalles Bibliográficos
Autores principales: Chukkalore, Divya, Rajavel, Anisha, Asti, Divya, Dhar, Meekoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351014/
https://www.ncbi.nlm.nih.gov/pubmed/37465112
http://dx.doi.org/10.3389/fonc.2023.1188028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351014/
https://www.ncbi.nlm.nih.gov/pubmed/37465112
http://dx.doi.org/10.3389/fonc.2023.1188028

Ejemplares similares